NEWTON, Mass., July 17, 2026--(BUSINESS WIRE)--Inflammasome Therapeutics today announced positive Phase 2 results for its investigational drug K8 in GA. Over six months, K8 was associated with ...
It took 100 years to come to fruition, but this recently created fluid enables non-magnetic electrostatic-based motors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results